https://www.thebody.com/category/kaletra-lopinavir-ritonavir
HIV Treatment and Medical Care

Kaletra (Lopinavir/Ritonavir)

The Latest

An Overview of Kaletra (Lopinavir/Ritonavir) Img

An Overview of Kaletra (Lopinavir/Ritonavir)

Brand Name: Kaletra Other Name(s): LPV / RTV, LPV/r, ritonavir-boosted lopinavir Drug Class: Protease Inhibitors

By AIDSinfo
Promo Image

Lopinavir + Ritonavir (Kaletra)

What Is Lopinavir? Who Should Take It? What About Drug Resistance? How Is It Taken? What Are the Side Effects? How Does It React With Other Drugs?

What Is Lopinavir?

Lopinavir is a drug used as part of antiretroviral therapy (ART). It i...

By AIDS InfoNet
Promo Image

Kaletra

Brand name: Kaletra

Generic name: lopinavir/ritonavir, or LPV/r

Class: Protease inhibitor (PI)

Manufacturer: Abbott Laboratories, www.kaletra.com, (800) 222-6885

AWP: $904.99/month for tablets, $420.95 for 160 mL solution

Standard Dose: Two tabl...

By Positively Aware
Promo Image
News

Once a Day Kaletra Gets Approved for Treatment Experienced, but With Caution

In April 2010, the FDA approved the once-a-day dosing of Kaletra (lopinavir + ritonavir) for adults who have taken HIV therapy before but with two or less lopinavir mutations. This new dose is not recommended for those with 3 or more of the following...

By Project Inform
Promo Image

Kaletra (Lopinavir/Ritonavir)

Kaletra tablets are light yellow-orange with the Abbott corporate logo and "KA" engraved on one side. Each tablet contains 200 mg of lopinavir and 50 mg of Norvir. A yellow-orange liquid formulation (42.4% alcohol) is also available, which contains 4...

By The Center for AIDS Information & Advocacy
Promo Image

Kaletra (ABT-378/r) Approved

On September 15, the FDA approved Kaletra™ (formerly called ABT-378/r), a protease inhibitor, for use in combination with other antiretroviral agents for treatment of HIV infection. Kaletra was already in use by several thousand patients, through a ...

By John S. James for AIDS Treatment News
Promo Image
News

Kaletra™ (ABT-378/r) Application for Accelerated Approval

On June 1 Abbott Laboratories announced that it had filed a New Drug Application with the U.S. FDA for accelerated approval of its new protease inhibitor, new brand name Kaletra (pronunciation Kuh Lee Truh) (generic name lopinavir/ritonavir, most wid...

By AIDS Treatment News